Delivery Order SPE2DB25D3404-SPE2DB25FUPFA
Award Date
7/10/25
Potential Completion Date
7/11/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,183.58 firm-fixed-price delivery order is for the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of May 29, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,446.10 firm fixed-price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has a completion date of March 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,275.45, is a Firm Fixed Price Delivery Order for the supply of 4564660868 RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has a completion date of May 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, involves the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,671.22, is a firm-fixed-price delivery order with a completion date of November 24, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026,...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $19,242.34 and is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,728.70 fixed-price delivery order is for the supply of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a completion date of September 6, 2024 and was awarded on September 5, 2024. Amerisourcebergen, a major U.S. pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite...
This federal contract award is a delivery order issued under a single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The IDC, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a potential value of $999,999,999.00 and is the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense....
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a ceiling value of $12,991.76 and a completion date of June 10, 2025. The contract is funded by the Medical Supply Chain, which is an alternate name for the Defense Logistics Agency (DLA). As a non-set-aside contract, it is open to full and open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,838.53 firm fixed-price delivery order contract has an ultimate completion date of April 22, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $2,932.56 firm fixed-price delivery order contract has a completion date of July 8, 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...